SOLARA ACTIVE PHARMA SCIENCES LIMITED — Board/Management Information 2025

Dec 5, 2025

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in

==> picture [184 x 50] intentionally omitted <==

December 05, 2025

The BSE Limited

Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051

Scrip Code: 541540, 890202

Symbol: SOLARA, SOLARAPP1

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) - Resignation of Whole Time Director and Chief Operating Officer of the Company.

Pursuant to the provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (hereinafter referred to as “ SEBI Listing Regulations ”), we hereby intimate that Mr. Mohan Muthunarayanan (DIN: 03610282), has tendered his resignation from the position of Whole Time Director (Executive Director) & Chief Operating Officer (Key Managerial Personnel) of the Company with effect from end of the business hours of December 31, 2025, consequent to his new role as Chief Operating Officer of Synthix Global Pharma Solutions Limited, a wholly owned subsidiary of Solara Active Pharma Sciences Limited (the Company), with a focus on developing its Polymers and CRAMs division and transforming the Vizag facility into a CDMO facility as stated in his Resignation Letter.

The Company places on record its sincere appreciation for Mr. Mohan Muthunarayanan’s valuable contributions and guidance during his tenure with the Company. The Company has benefitted immensely from his experience, judgment, and unwavering commitment.

The details as required under Schedule III of Listing Regulations read with SEBI Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and SEBI Circular SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024 are given in "Annexure-A" attached to this letter. The Resignation Letter received from Mr. Mohan Muthunarayanan is enclosed herewith as “Annexure-B”.

The above information will be made available on the Company’s website at www.solara.co.in

We request you to take the same on record.

Thanking you,

Yours faithfully,

For Solara Active Pharma Sciences Limited

Digitally signed by POOJA JAYA POOJA JAYA KUMAR KUMAR Date: 2025.12.05 18:09:06 +05'30'

Pooja Jaya Kumar Company Secretary ICSI Membership No. A57415

Encl.: As above

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703 / Tel: +91- 22-20870033

==> picture [184 x 50] intentionally omitted <==

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in

Annexure A

Details of as required under Schedule III of SEBI Listing Regulations, read with SEBI Master - Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 and SEBI/HO/CFD/CFD PoD-2/CIR/P/2024/185 dated December 31, 2024

Sr. No.	Particulars	Resignation of Mr. Mohan Muthunarayanan
1.	Reason for Change	Mr. Mohan Muthunarayanan (DIN: 03610282) has tendered his resignation from the position of Whole Time Director (Executive Director) & Chief Operating Officer, consequent to his new role as Chief Operating Officer of Synthix Global Pharma Solutions Limited, a wholly owned subsidiary of Solara, with a focus on developing its Polymers and CRAMs division and transforming the Vizag facility into a CDMO facility, as stated in the Resignation Letter attached.
2.	Date of~~appointment/~~cessation (as applicable) & term of appointment	close of business hours on December 31, 2025
3.	Brief Profile	Not Applicable
4.	Disclosure of relationships between directors	Not applicable

For Solara Active Pharma Sciences Limited

POOJA Digitally signed by POOJA JAYA JAYA KUMAR Date: 2025.12.05 KUMAR 18:09:24 +05'30' Pooja Jaya Kumar Company Secretary ICSI Membership No. A57415

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703 / Tel: +91- 22-20870033

Annexure B

==> picture [479 x 539] intentionally omitted <==